Drug profile

The FDA adverse-event record for Lincomycin Hydrochloride

45 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Lincomycin Hydrochloride. See the species affected, top reactions, and outcomes below.

45
adverse-event reports
13.3%
death-coded share
Pig
most-reported species
10
Lack of efficacy (bacteria) - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
45
Total Reports
6
Deaths Reported
13.3%
Death Rate

Active Ingredients

Lincomycin Hydrochloride

Administration Routes

UnknownOralIntramuscularSubcutaneousTopicalParenteral

Species Affected

Pig 16
Unknown 13
Dog 9
Cat 3
Human 3
Cattle 1

Most Affected Breeds

Unknown 16
Crossbred Porcine/Pig 11
Pig (unknown) 4
Spaniel - Cocker American 2
Retriever - Labrador 2
Terrier - Boston 1
Domestic (unspecified) 1
Pit Bull 1
Chow Chow 1
Retriever - Chesapeake Bay 1

Most Reported Reactions

Lack of efficacy (bacteria) - NOS 10
Diarrhoea 5
Product Defect, General 3
Increased mortality rate 3
No sign 2
Pruritus 2
Vomiting 2
Containers, Damaged 2
Urticaria 2
Depression 2
Death 2
Underfilling, Bottles 2

Outcome Breakdown

Outcome Unknown
13 (50.0%)
Died
6 (23.1%)
Recovered/Normal
4 (15.4%)
Ongoing
3 (11.5%)

Lincomycin Hydrochloride Adverse Event Insights

45 reports name Lincomycin Hydrochloride; 6 recorded a death outcome (13.3% of reported events, not a population-level mortality rate). Active ingredient: Lincomycin Hydrochloride. Administration routes: Unknown, Oral, Intramuscular, Subcutaneous.

By species: Pig (16 reports), Unknown (13 reports), Dog (9 reports). By breed: Unknown (16), Crossbred Porcine/Pig (11), Pig (unknown) (4).

Leading clinical signs: Lack of efficacy (bacteria) - NOS (10), Diarrhoea (5), Product Defect, General (3), Increased mortality rate (3). Outcome, 26 coded reports: Outcome Unknown leads at 50.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.